GPT and Cirrhosis: Government‐funded antiviral therapy is generally provided for those with elevated ALT and HBV DNA levels above 2000 IU/mL (HBeAg negative) or 20,000 IU/mL (HBeAg positive), with the exception being those with cirrhosis who only require detectable HBV DNA.24